Recall Enforment Report D-0339-2019
Recall Details
Drug Recall Enforcement Report Class II voluntary initiated by Pfizer Inc., originally initiated on 12-06-2018 for the product Levoxyl (levothyroxine sodium tablets, USP) tablets 112 mcg, 100-count bottle, Rx Only,Distributed by Pfizer Inc. New York, NY 10017, NDC 60793-855-01 The product was recalled due to superpotent drug.. The product was distributed nationwide and the recall is currently terminated.
Recalled Products
NDC | Proprietary Name | Non-Proprietary Name | Dosage Form | Route Name | Company Name | Product Type |
---|---|---|---|---|---|---|
60793-850 | Levoxyl | Levothyroxine Sodium | Tablet | Oral | Pfizer Laboratories Div Pfizer Inc | Human Prescription Drug |
60793-851 | Levoxyl | Levothyroxine Sodium | Tablet | Oral | Pfizer Laboratories Div Pfizer Inc | Human Prescription Drug |
60793-852 | Levoxyl | Levothyroxine Sodium | Tablet | Oral | Pfizer Laboratories Div Pfizer Inc | Human Prescription Drug |
60793-853 | Levoxyl | Levothyroxine Sodium | Tablet | Oral | Pfizer Laboratories Div Pfizer Inc | Human Prescription Drug |
60793-854 | Levoxyl | Levothyroxine Sodium | Tablet | Oral | Pfizer Laboratories Div Pfizer Inc | Human Prescription Drug |
60793-855 | Levoxyl | Levothyroxine Sodium | Tablet | Oral | Pfizer Laboratories Div Pfizer Inc | Human Prescription Drug |
60793-856 | Levoxyl | Levothyroxine Sodium | Tablet | Oral | Pfizer Laboratories Div Pfizer Inc | Human Prescription Drug |
60793-857 | Levoxyl | Levothyroxine Sodium | Tablet | Oral | Pfizer Laboratories Div Pfizer Inc | Human Prescription Drug |
60793-858 | Levoxyl | Levothyroxine Sodium | Tablet | Oral | Pfizer Laboratories Div Pfizer Inc | Human Prescription Drug |
60793-859 | Levoxyl | Levothyroxine Sodium | Tablet | Oral | Pfizer Laboratories Div Pfizer Inc | Human Prescription Drug |
60793-860 | Levoxyl | Levothyroxine Sodium | Tablet | Oral | Pfizer Laboratories Div Pfizer Inc | Human Prescription Drug |